2014
DOI: 10.1111/neup.12187 View full text |Buy / Rent full text
|
|

Abstract: Glioblastomas (GBMs) are the most aggressive type of primary brain tumors and provide a dismal prognosis. Thus far, several key genes have been identified in GBMs as prognostic and therapeutic targets. Mutations in two isocitrate dehydrogenase (IDH) genes, IDH1 and IDH2, commonly occur in low-grade gliomas and secondary high-grade gliomas, but are rare in primary GBMs. These mutations alter the catalytic activity of IDH proteins, promoting gliomagenesis. Gliomas with IDH1 or IDH2 mutation have better outcomes … Show more

Help me understand this page

Search citation statements

Order By: Relevance
0
0
0
0
0
0
11
0

Publication Types

Select...

Relationship

0
0

Authors

Journals